Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raby

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|July 1, 1991
Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodolP J Johnson, C Kalayci, N Dobbs, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcomeEfrat Aharonovich, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|June 12, 2010
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in periodAdam Bisaga, Efrat Aharonovich, Wendy Y Cheng, et al.
Drug and Alcohol Dependence|December 21, 2004
Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga, Efrat Aharonovich, Fatima Garawi, et al.
The American Journal on Addictions|August 16, 2011
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekersElias Dakwar, Edward V Nunes, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinomaT R J Evans, G Pentheroudakis, J Paul, et al.
BJU International|June 26, 2003
Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatmentG Pentheroudakis, J S De Bono, S B Kaye, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
Drug and Alcohol Dependence|August 8, 2007
Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan, Fatima Garawi, Adam Bisaga, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|July 1, 1991
Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodolP J Johnson, C Kalayci, N Dobbs, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcomeEfrat Aharonovich, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|June 12, 2010
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in periodAdam Bisaga, Efrat Aharonovich, Wendy Y Cheng, et al.
Drug and Alcohol Dependence|December 21, 2004
Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga, Efrat Aharonovich, Fatima Garawi, et al.
The American Journal on Addictions|August 16, 2011
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekersElias Dakwar, Edward V Nunes, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinomaT R J Evans, G Pentheroudakis, J Paul, et al.
BJU International|June 26, 2003
Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatmentG Pentheroudakis, J S De Bono, S B Kaye, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
Drug and Alcohol Dependence|August 8, 2007
Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan, Fatima Garawi, Adam Bisaga, et al.
Pageof 7